CyberGene Overview

  • Founded
  • 1995
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • M&A
  • (Announced)
  • Investors
  • 2

CyberGene General Information

Description

Developer of diagnostic kits designed to detect chromosomal disorders in humans. The company's diagnostic kits include in-vitro diagnostic kits and ready-made mixes of primers and probes, enabling doctors to avail analysis of chromosomal disorders in prenatal diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • Banvaktsvägen 22
  • 171 48 Solna
  • Sweden
+46 060-823 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CyberGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 25-May-2021 Announced Generating Revenue
3. Secondary Transaction - Private Completed Startup
2. Later Stage VC 01-Dec-2007 Completed Startup
1. Early Stage VC 15-Feb-1999 Completed Startup
To view CyberGene’s complete valuation and funding history, request access »

CyberGene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of diagnostic kits designed to detect chromosomal disorders in humans. The company's diagnostic kits include i
Diagnostic Equipment
Solna, Sweden
4 As of 2021
000000&0

00000000

llamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vo
0000000000 000000000
Manchester, United Kingdom
0 As of 0000
00.00 0000-00-00
000000&0

0000000

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mo
0000000000 000000000
Hägersten, Sweden
000.00
0000000 0000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CyberGene Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Elucigene Diagnostics Formerly PE-Backed Manchester, United Kingdom 0 000000&0
0000000 Private Equity-Backed Hägersten, Sweden 000.00 0000000 0000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

CyberGene Executive Team (2)

Name Title Board Seat Contact Info
Heléne Olsson Co-Founder, Chief Executive Officer, Board Member & Managing Director
Jan Olsson Ph.D Board Member & Co-Founder
To view CyberGene’s complete executive team members history, request access »

CyberGene Board Members (3)

Name Representing Role Since
Anders Reisch CyberGene Chairman 000 0000
Heléne Olsson CyberGene Co-Founder, Chief Executive Officer, Board Member & Managing Director 000 0000
Jan Olsson Ph.D CyberGene Board Member & Co-Founder 000 0000
To view CyberGene’s complete board members history, request access »

CyberGene Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CyberGene Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Stockholm Innovation & Growth Accelerator/Incubator Minority 000 0000 000000 0
3i Group PE/Buyout Minority 000 0000 000000 0
To view CyberGene’s complete investors history, request access »